Bioburden Testing Market Size, Industry Analysis Report, Regional Outlook, Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027
Report ID: GMI3869
Bioburden Testing Market size is projected to experience significant growth from 2019 to 2025.
The number of microorganisms living on any surface which has not been sterilized is called as bioburden. Bioburden testing is also called as microbial limit testing. This test is performed for quality control purposes on medical products and pharmaceutical products. In the field of pharmacy or medicine, the products or components used are needed to have microbial levels under control during handling and processing. The microbial limit testing or bioburden testing done on these products is done to find out that whether the requirements have been met or not. Bioburden testing is also done for assembly processes in manufacturing and routine monitoring of products and raw materials. The prime objective for conducting bioburden tests is to ensure safety.
The increasing number of medical devices will drive the bioburden testing market over the forecast period. Also, rising standards for quality control as per regulatory bodies and growing awareness amongst customer base of medical devices are driving the global bioburden testing market.
With advancements in pharmaceutical and medical field, the demand for bioburden tests will rise. Flourishing biotechnology industry will augment the growth of bioburden testing market over the forthcoming years. Safety concerns for consumables such as food and beverages increasing, and market players involved in this business are making sure the requirements are met. Such factors will boost the bioburden testing market in the forthcoming years.
Moreover, technological developments related to improvements in the bioburden testing are major factors that will drive market growth. However, stringent government regulations, product recalls, high costs related to the bioburden testing equipment could restrict industry growth especially in emerging economies.
The contract manufacturing organization segment is expected to show the highest CAGR by end-use in the global bioburden testing market throughout the forecast period due to high rate of manufacturing outsourcing in biotechnology and pharmaceutical companies. The key factor contributing to the growth of raw material testing market is the improving quality standards for finished products throughout the globe.
The U.S. held the largest share in the global bioburden testing market in 2018 due to the availability of highly developed healthcare infrastructure, huge investment in pharmaceutical R&D, advanced technology as well as the presence of major market players in the region. Furthermore, the high healthcare expenditure will fuel market growth.
Japan is expected to show significant growth in the bioburden testing market over the forecast period due to advancements in technology, rising quality standards in biotechnology and pharmacy and growing developments in the healthcare infrastructure. The above-mentioned factors will boost the demand for Bioburden Testing.
Some of the key industry players include Charles River, Merck KGaA, SGS SA, WuXi AppTec, Becton, Dickinson and Company, NAMSA, Nelson Laboratories, LLC, Thermo Fisher Scientific, biomérieux SA, and Pacific BioLabs. Major strategic initiatives adopted by industry players include partnerships, mergers and innovative product launches to expand their business product portfolio.
Bioburden Testing Market by Product, 2014-2025 (USD Million)
Bioburden Testing Market by Test, 2014-2025 (USD Million)
Bioburden Testing Market by Application, 2014-2025 (USD Million)
- Raw Material
- Medical Device
- Sterility Testing
Bioburden Testing Market by End-use, 2014-2025 (USD Million)
- Contract Manufacturing Organization
The above information is provided for the following regions and countries:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
- Saudi Arabia
- South Africa
- Charles River
- Merck KGaA
- SGS SA
- WuXi AppTec
- Becton, Dickinson and Company
- Nelson Laboratories LLC
- Thermo Fisher Scientific
- Biomérieux SA
- Pacific BioLabs
What Information does this report contain?
Customize this Report
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability
Benefits of Association
Data Coverage & Quality
GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.
Client Trust & Security
GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.
Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.